arno therapeutics inc  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports arno therapeutics inc  product pipeline review   arno therapeutics inc  product pipeline review   wgr  july  global  pages global markets direct description table of content sample report enquiry before buy related reports arno therapeutics inc  product pipeline review  summaryglobal markets direct’s ‘arno therapeutics inc  product pipeline review  ’ provides an overview of the arno therapeutics inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of arno therapeutics inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescope the report provides brief overview of arno therapeutics inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of arno therapeutics inc’s human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement  latest news and deals relating to the arno therapeutics inc’s pipeline productsreasons to buy evaluate arno therapeutics inc’s strategic position with total access to detailed information on its product pipeline assess the growth potential of arno therapeutics inc in its therapy areas of focus identify new drug targets and therapeutic classes in the arno therapeutics inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of arno therapeutics inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of arno therapeutics inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of arno therapeutics inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contentstable of contents list of tables list of figures arno therapeutics inc snapshot arno therapeutics inc overview key information key facts arno therapeutics inc  research and development overview key therapeutic areas arno therapeutics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy arno therapeutics inc  pipeline products glance arno therapeutics inc  clinical stage pipeline products phase i productscombination treatment modalities arno therapeutics inc  early stage pipeline products preclinical productscombination treatment modalities arno therapeutics inc  drug profiles ar product description mechanism of action rd progress onapristone er product description mechanism of action rd progress ar product description mechanism of action rd progress arno therapeutics inc  pipeline analysis arno therapeutics inc  pipeline products by target arno therapeutics inc  pipeline products by route of administration arno therapeutics inc  pipeline products by molecule type arno therapeutics inc  pipeline products by mechanism of action arno therapeutics inc  recent pipeline updates arno therapeutics inc  dormant projects arno therapeutics inc  discontinued pipeline products discontinued pipeline product profiles ar arno therapeutics inc  company statement arno therapeutics inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablesarno therapeutics inc key information arno therapeutics inc key facts arno therapeutics inc  pipeline by indication  arno therapeutics inc  pipeline by stage of development  arno therapeutics inc  monotherapy products in pipeline  arno therapeutics inc  phase i  arno therapeutics inc  preclinical  arno therapeutics inc  pipeline by target  arno therapeutics inc  pipeline by route of administration  arno therapeutics inc  pipeline by molecule type  arno therapeutics inc  pipeline products by mechanism of action  arno therapeutics inc  recent pipeline updates  arno therapeutics inc  dormant developmental projects arno therapeutics inc  discontinued pipeline products  list of figuresarno therapeutics inc  pipeline by top  indication  arno therapeutics inc  pipeline by stage of development  arno therapeutics inc  monotherapy products in pipeline  arno therapeutics inc  pipeline by top  target  arno therapeutics inc  pipeline by top  route of administration  arno therapeutics inc  pipeline by top  molecule type  arno therapeutics inc  pipeline products by top  mechanism of action   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send arno therapeutics inc private company information  bloomberg july    am et biotechnology company overview of arno therapeutics inc snapshot people company overview arno therapeutics inc a biopharmaceutical company develops products for the treatment of cancer and other life threatening diseases the company’s product development pipeline includes onapristone a type  antiprogestin hormone blocker that is in phase iii clinical study for the treatment of breast endometrial and others solid tumors in postmenopausal women and advanced castrationresistant prostate cancer in men its product development pipeline also consists of ar an orally available cancer treatment which has completed phase i clinical study for the treatment of solid tumors and hematological malignancies as well as in preclinical studies for the treatment of various ant arno therapeutics inc a biopharmaceutical company develops products for the treatment of cancer and other life threatening diseases the company’s product development pipeline includes onapristone a type  antiprogestin hormone blocker that is in phase iii clinical study for the treatment of breast endometrial and others solid tumors in postmenopausal women and advanced castrationresistant prostate cancer in men its product development pipeline also consists of ar an orally available cancer treatment which has completed phase i clinical study for the treatment of solid tumors and hematological malignancies as well as in preclinical studies for the treatment of various antimicrobial targets in addition the company’s product development pipeline comprises ar a novel orally available cancer therapy that is in phase i investigatorinitiated clinical study for the treatment of hematological malignancies and solid tumors the company has license agreements with invivis pharmaceuticals inc the regents of the university of minnesota and the ohio state university innovation foundation as well as a codevelopment agreement with leica biosystems newcastle ltd arno therapeutics inc is based in flemington new jersey detailed description  route  northsuite flemington nj united states employees phone  fax  wwwarnotheracom key executives for arno therapeutics inc dr alexander a zukiwski md chief executive officer president chief medical officer and director age  total annual compensation k dr stefan proniuk phd mba chief development officer age  total annual compensation k compensation as of fiscal year  arno therapeutics inc key developments arno therapeutics files form  mar   arno therapeutics inc has announced that it has filed a form  with the securities and exchange commission to voluntarily deregister its common stock par value  per share under the securities exchange act of  as amended arno therapeutics seeks acquisitions jan   arno therapeutics inc otcpkarni is seeking acquisitions and potential development opportunities to grow further arno therapeutics inc specialextraordinary shareholders meeting dec   nov   arno therapeutics inc specialextraordinary shareholders meeting dec   at  us eastern standard time location  route  north suite  flemington nj  united states agenda to authorize the amendment of certificate of incorporation to effect a combination reverse split of common stock at a ratio of for and to authorize the amendment of certificate of incorporation to reduce the number of authorized shares of common stock from  to  similar private companies by industry company name region n labs inc united states andme inc united states c tech corporation inc united states v biosciences inc united states bar biologics inc united states recent private companies transactions typedate target private placement august    request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact arno therapeutics inc please visit wwwarnotheracom company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close arno therapeutics inc  product pipeline review   infomarketreportscentercom  us x login sign up facebook twitter linkedin google  mrc blog youtube arno therapeutics inc  product pipeline review   home  pharmaceuticals  global markets direct  arno therapeutics inc  product pipeline review   report details arno therapeutics inc  product pipeline review   sku gmdsep category pharmaceuticals publisher global markets direct pages  published aug skugmdsep categorypharmaceuticals publisherglobal markets direct pages published onaug request discount pay by wireinvoice description table of content list of figures request sample description arno therapeutics inc  product pipeline review   summary global markets directs arno therapeutics inc  product pipeline review   provides an overview of the arno therapeutics incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of arno therapeutics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope  the report provides brief overview of arno therapeutics inc including business description key information and facts and its locations and subsidiaries  the report reviews current pipeline of arno therapeutics incs human therapeutic division and enlists all their major and minor projects  the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones  special feature on outlicensed and partnered product portfolio  the report summarizes all the dormant and discontinued pipeline projects  latest company statement  latest news and deals relating to the arno therapeutics incs pipeline products reasons to buy  evaluate arno therapeutics incs strategic position with total access to detailed information on its product pipeline  assess the growth potential of arno therapeutics inc in its therapy areas of focus  identify new drug targets and therapeutic classes in the arno therapeutics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas  exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps  develop strategic initiatives by understanding the focus areas of arno therapeutics inc and exploit collaboration and partnership opportunities  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  plan mergers and acquisitions effectively by identifying the most promising pipeline of arno therapeutics inc  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope  explore the dormant and discontinued projects of arno therapeutics inc and identify potential opportunities in those areas  avoid intellectual property rights related issues newspress release precision medicine how the life science industry can improve outcomes through to achieve successful precision medicine at scale and to be able to offer it as an everyday treatment option researchers in drug rd need to better understand and manage the reams of unstructured datread more regenerative medicine market to hit  billion by  the current regenerative medicine market is worth  billion globally and will hit over  billion by  as impact of trump administrationread more  benefits of microneedlingmicroneedling hundreds of tiny pin pricks going into your skin might sound weird but it could just be the best thing that ever happened to your faceread more table of content table of contents table of contents  list of tables  list of figures  arno therapeutics inc snapshot  arno therapeutics inc overview  key information  key facts  arno therapeutics inc  research and development overview  key therapeutic areas  arno therapeutics inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  arno therapeutics inc  pipeline products glance  arno therapeutics inc  clinical stage pipeline products  phase ii productscombination treatment modalities  phase i productscombination treatment modalities  phase  productscombination treatment modalities  arno therapeutics inc  early stage pipeline products  preclinical productscombination treatment modalities  arno therapeutics inc  drug profiles  onapristone er  product description  mechanism of action  rd progress  ar  product description  mechanism of action  rd progress  ar  product description  mechanism of action  rd progress  arno therapeutics inc  pipeline analysis  arno therapeutics inc  pipeline products by target  arno therapeutics inc  pipeline products by route of administration  arno therapeutics inc  pipeline products by molecule type  arno therapeutics inc  pipeline products by mechanism of action  arno therapeutics inc  recent pipeline updates  arno therapeutics inc  dormant projects  arno therapeutics inc  discontinued pipeline products  discontinued pipeline product profiles  ar  arno therapeutics inc  company statement  arno therapeutics inc  locations and subsidiaries  head office  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of figures list of tables arno therapeutics inc key information  arno therapeutics inc key facts  arno therapeutics inc  pipeline by indication   arno therapeutics inc  pipeline by stage of development   arno therapeutics inc  monotherapy products in pipeline   arno therapeutics inc  phase ii   arno therapeutics inc  phase i   arno therapeutics inc  phase    arno therapeutics inc  preclinical   arno therapeutics inc  pipeline by target   arno therapeutics inc  pipeline by route of administration   arno therapeutics inc  pipeline by molecule type   arno therapeutics inc  pipeline products by mechanism of action   arno therapeutics inc  recent pipeline updates   arno therapeutics inc  dormant developmental projects  arno therapeutics inc  discontinued pipeline products   list of figures arno therapeutics inc  pipeline by top  indication   arno therapeutics inc  pipeline by stage of development   arno therapeutics inc  monotherapy products in pipeline   arno therapeutics inc  pipeline by top  target   arno therapeutics inc  pipeline by top  route of administration   arno therapeutics inc  pipeline by top  molecule type   arno therapeutics inc  pipeline products by top  mechanism of action   please select license type single user electronic pdf   site user electronic pdf   enterprise wide electronic pdf   add to cart buy now related reports global oncology market to   robust growth driven by rising prevalence and increased uptake of immune checkpoint inhibitors urinary incontinence  pipeline review h  ict investment trends in china enterprises initiatives inclined towards digitization fuelling ict investments global pain therapeutics market to   innovative new products to address unmet need within chronic pain and migraine and tackle opioid abuse global veterinary therapeutics market research report  request sample mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send request discount mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send pay by wireinvoice mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  single user electronic pdf site user electronic pdf enterprise wide electronic pdf cd rom hard copy send request quote mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send market reports center  copyright  all rights reserved arno therapeutics inc  product pipeline review    compare about us  contact us home research category publisher list custom research cart compare research category user guide policies contact us about us site map home  market research report  pharmaceutical  pharmaceutical companies  pharma info market research report arno therapeutics inc  product pipeline review   published by global markets direct product code  published august   content info  pages price usd  pdf by email single user license usd  pdf by email site license usd  pdf by email global license arno therapeutics inc  product pipeline review   published august   content info  pages description summary global markets directs arno therapeutics inc  product pipeline review   provides an overview of the arno therapeutics incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of arno therapeutics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope the report provides brief overview of arno therapeutics inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of arno therapeutics incs human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the arno therapeutics incs pipeline products reasons to buy evaluate arno therapeutics incs strategic position with total access to detailed information on its product pipeline assess the growth potential of arno therapeutics inc in its therapy areas of focus identify new drug targets and therapeutic classes in the arno therapeutics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of arno therapeutics inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of arno therapeutics inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of arno therapeutics inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contents product code gmdhccdbtable of contents table of contents list of tables list of figures arno therapeutics inc snapshot arno therapeutics inc overview key information key facts arno therapeutics inc  research and development overview key therapeutic areas arno therapeutics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy arno therapeutics inc  pipeline products glance arno therapeutics inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities phase  productscombination treatment modalities arno therapeutics inc  early stage pipeline products preclinical productscombination treatment modalities arno therapeutics inc  drug profiles onapristone er product description mechanism of action rd progress ar product description mechanism of action rd progress ar product description mechanism of action rd progress arno therapeutics inc  pipeline analysis arno therapeutics inc  pipeline products by target arno therapeutics inc  pipeline products by route of administration arno therapeutics inc  pipeline products by molecule type arno therapeutics inc  pipeline products by mechanism of action arno therapeutics inc  recent pipeline updates arno therapeutics inc  dormant projects arno therapeutics inc  discontinued pipeline products discontinued pipeline product profiles ar arno therapeutics inc  company statement arno therapeutics inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tables arno therapeutics inc key information arno therapeutics inc key facts arno therapeutics inc  pipeline by indication  arno therapeutics inc  pipeline by stage of development  arno therapeutics inc  monotherapy products in pipeline  arno therapeutics inc  phase ii  arno therapeutics inc  phase i  arno therapeutics inc  phase   arno therapeutics inc  preclinical  arno therapeutics inc  pipeline by target  arno therapeutics inc  pipeline by route of administration  arno therapeutics inc  pipeline by molecule type  arno therapeutics inc  pipeline products by mechanism of action  arno therapeutics inc  recent pipeline updates  arno therapeutics inc  dormant developmental projects arno therapeutics inc  discontinued pipeline products  list of figures arno therapeutics inc  pipeline by top  indication  arno therapeutics inc  pipeline by stage of development  arno therapeutics inc  monotherapy products in pipeline  arno therapeutics inc  pipeline by top  target  arno therapeutics inc  pipeline by top  route of administration  arno therapeutics inc  pipeline by top  molecule type  arno therapeutics inc  pipeline products by top  mechanism of action  phone intl  tollfreeus  europe  asia  new for   gii now purchases any market research reports from any publishers for you with noextra cost contact us for more details faq delivery time user license payment options compare multiple reports about contact user guide policies site map  copyright  global information inc all rights reserved arniotc us stock quote  arno therapeutics inc  bloomberg markets error could not add to watchlist x  watchlist arno therapeutics inc arnius otc us usd   as of  pm edt  open  day range    volume  previous close  wk range     yr return  before its here its on the bloomberg terminal learn more open  day range    volume  previous close  wk range     yr return  ytd return  current pe ratio ttm  earnings per share usd ttm  market cap m usd  shares outstanding m  pricesales ttm  dividend indicated gross yield  sector health care  price change  industry pharmaceuticals biotechnology  life sciences  price change  related videos there are currently no related videos for this ticker please check back later company news press releases there are currently no news stories for this ticker please check back later  prostate cancer pipeline h  therapeutic key players v biosciences inc sc ag actinium pharmaceuticals inc and advaxis  myelodysplastic syndrome pipeline therapeutic drugs and companies review h  research report available at rnrmarketresearch  h pipeline on hodgkin lymphoma bcell hodgkin lymphoma for  market therapeutics growth and assessment at  arno therapeutics announces plan to deregister its common stock there are currently no press releases for this ticker please check back later profile arno therapeutics inc is a developmentstage company the company acquires develops and commercializes products for the treatment of cancer arno seeks to acquire rights to novel preclinical or early stage clinical oncology product candidates primarily from academic and research institutions address  campus drive nd floorparisppany nj united states phone  website wwwarnotheracom executives board members alexander a zukiwski alex ceochief medical officerir stefan proniuk chief development officer david m tanen secretarycofounder show more arno therapeutics inc  product pipeline review    reportsnreports market research report welcome guest    registerlogin   contact us   about us      advanced search home ›  pharmaceuticals ›  report detail arno therapeutics inc  product pipeline review   published july  no of pages  price  single user license us   corporate user license us     report description table of contents inquire before buying global markets directs arno therapeutics inc product pipeline review  provides an overview of the arno therapeutics incs pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of arno therapeutics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescopethe report provides brief overview of arno therapeutics inc including business description key information and facts and its locations and subsidiariesthe report reviews current pipeline of arno therapeutics incs human therapeutic division and enlists all their major and minor projectsthe report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestonesspecial feature on outlicensed and partnered product portfoliothe report summarizes all the dormant and discontinued pipeline projectslatest company statementlatest news and deals relating to the arno therapeutics incs pipeline productsreasons to buyevaluate arno therapeutics incs strategic position with total access to detailed information on its product pipelineassess the growth potential of arno therapeutics inc in its therapy areas of focusidentify new drug targets and therapeutic classes in the arno therapeutics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areasexploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gapsdevelop strategic initiatives by understanding the focus areas of arno therapeutics inc and exploit collaboration and partnership opportunitiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantageplan mergers and acquisitions effectively by identifying the most promising pipeline of arno therapeutics incdevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeexplore the dormant and discontinued projects of arno therapeutics inc and identify potential opportunities in those areasavoid intellectual property rights related issues arno therapeutics inc  product pipeline review   table of contentstable of contents list of tables list of figures arno therapeutics inc snapshot arno therapeutics inc overview key information key facts arno therapeutics inc  research and development overview key therapeutic areas arno therapeutics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy arno therapeutics inc  pipeline products glance arno therapeutics inc  clinical stage pipeline products phase i productscombination treatment modalities arno therapeutics inc  early stage pipeline products preclinical productscombination treatment modalities arno therapeutics inc  drug profiles ar product description mechanism of action rd progress onapristone er product description mechanism of action rd progress ar product description mechanism of action rd progress arno therapeutics inc  pipeline analysis arno therapeutics inc  pipeline products by target arno therapeutics inc  pipeline products by route of administration arno therapeutics inc  pipeline products by molecule type arno therapeutics inc  pipeline products by mechanism of action arno therapeutics inc  recent pipeline updates arno therapeutics inc  dormant projects arno therapeutics inc  discontinued pipeline products discontinued pipeline product profiles ar arno therapeutics inc  company statement arno therapeutics inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablesarno therapeutics inc key information arno therapeutics inc key facts arno therapeutics inc  pipeline by indication  arno therapeutics inc  pipeline by stage of development  arno therapeutics inc  monotherapy products in pipeline  arno therapeutics inc  phase i  arno therapeutics inc  preclinical  arno therapeutics inc  pipeline by target  arno therapeutics inc  pipeline by route of administration  arno therapeutics inc  pipeline by molecule type  arno therapeutics inc  pipeline products by mechanism of action  arno therapeutics inc  recent pipeline updates  arno therapeutics inc  dormant developmental projects arno therapeutics inc  discontinued pipeline products  list of figuresarno therapeutics inc  pipeline by top  indication  arno therapeutics inc  pipeline by stage of development  arno therapeutics inc  monotherapy products in pipeline  arno therapeutics inc  pipeline by top  target  arno therapeutics inc  pipeline by top  route of administration  arno therapeutics inc  pipeline by top  molecule type  arno therapeutics inc  pipeline products by top  mechanism of action   published by global markets direct product code global markets direct did you find what you arewere looking for  if not read below and browse through other relevant pages for similar market research reports or get in touch with us through the formcontact info in your right navigation panel and well share relevant market report titles for you to explore related reports europe veterinary vaccine market by manufacturers countries type and application forecast to  vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from diseasecausing agents vaccines stimulate the immune systems production of antibodies that identify and destroy dis europe injectable anticoagulants market by manufacturers countries type and application forecast to  the injectable anticoagulants include low molecular weight heparin lmwh agents dalteparin fragmin enoxaparin lovenox and factor xa inhibitors fondaparinux arixtra in general the injectable anticoagulants are food and drug admini europe ginseng extract market by manufacturers countries type and application forecast to  ginseng is a plant characterized by a fleshy root and a single stalk with green ovalshaped leaves it is a perennial plant that can live more than a century ginseng is typically derived from the root of this plant as an herbal supplement the extr europe dunaliella market by manufacturers countries type and application forecast to  dunaliella is a genus of the algae family dunaliellaceae it is widely distributed in natural habitat ranging from ocean and lakes of saturated brine dunaliella is unicellular biflagellate naked greenalga with ovoid in shape without cell wall  europe anticoagulants market by manufacturers countries type and application forecast to  anticoagulants commonly referred to as blood thinners are substances that prevent or reduce coagulation of blood prolonging the clotting time some of them occur naturally in bloodeating animals such as leeches and mosquitoes where they help kee north america physiological saline market by manufacturers countries type and application forecast to  physiological saline is a mixture of sodium chloride in water and has a number of uses in medicine applied to the affected area it is used to clean wounds help remove contact lenses and help with dry eyes by injection into a vein it is used to tr global newcastle disease vaccine market by manufacturers countries type and application forecast to  newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species it is transmissible to humans newcastle disease can be controlled by the use of vaccines there are many newcastle disease vaccines suitable for global onychomycosis tinea unguium drug detailed analysis report  this report splits onychomycosis tinea unguium drug by product drug form by product usage type this shares the history data information from  to  and forecast from  to  and this report mainly introduces volume and value marke  united states vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in united states from the xx million usd in  with a cagr compound annual growth rate xx fro  united states tuberculin market report status and outlook this report will be delivered in  business days after the order is placed the tuberculin market size will be xx million usd in  in united states from the xx million usd in  with a cagr compound annual growth rate xx from  why reportsnreportscom  market research reports and growing top fortune  organizations trust us for research data  support on call as well as emails your details are safe with us free support for your research requirements report delivery email delivery time upto  hrs  working days upto  hrs max  weekends and public holidays research support  custom research if this business study does not have the data and information analysis you need contact us with your research requirements we explore available market research reports to map your needs and share report titles with you alternatively we can also offer custom research that suits your budget and timelines share your information requirements here connect with us email salesreportsandreportscom call       home category publisher country latest reports markets discounted reports upcoming reports contact us subscription option using our subscription option you get access to market research reports and industry data of consumer goods market as per your needs get the best of consumer goods research reports by utilizing your research budgets in an optimum way more about our subscription option report alerts get email alerts about market research reports from industries and publishers of your interest please enter a valid email id thank you you have successfully subscribed to our report alerts avail upto  discount on below publisher reports technavio azoth analytics   reportsnreports all rights reserved disclamer privacy policy  terms and conditions  our market research blog  sitemap feeds rss  latest reports arni key statistics  arno therapeutics inc financial ratios  marketwatch bulletin investor alert london markets open in asia markets currencies us market snapshot expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close arno therapeutics inc otc arni go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus arno therapeutics inc market closed  quotes are delayed by  min jul    pm arni quoteszigmandelayed   change   volume volume  quotes are delayed by  min quoteszigmandelayed previous close     change   day low day high    week low  week high   company description arno therapeutics inc operates as a biopharmaceutical company which focuses on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs it develops preclinical and clinicalstage product under the following brands onapristone ar and ar th arno therapeutics inc operates as a biopharmaceutical company which focuses on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs it develops preclinical and clinicalstage product under the following brands onapristone ar and ar the company was founded by peter morgan kash david m tanen and joshua a kazam in march  and is headquartered in flemington nj valuation pe current  pe ratio with extraordinary items  enterprise value to ebitda  total debt to enterprise value  efficiency income per employee  liquidity current ratio  quick ratio  cash ratio  profitability return on assets  capital structure total debt to total assets  officers and executives name age officer since title dr alexander a zukiwski   ceo principal financial officer  director insider actions – purchase – sale  – number of transactions  date name shares transaction value  david m tanen secretary director    acquisition at  per share   arie s belldegrun director    acquisition at  per share   pontifax management co ltd director    acquisition at  per share   pontifax management co ltd director    acquisition at  per share   pontifax management co ltd director    acquisition at  per share   david m tanen secretary director    acquisition at  per share   alexander a zukiwski chief executive officer  cmo director    acquisition at  per share   commercial street capital llc    award at  per share   arie s belldegrun director    award at  per share   arie s belldegrun director    award at  per share   arie s belldegrun director    award at  per share   arie s belldegrun director    award at  per share   alexander a zukiwski chief executive officer  cmo director    award at  per share   glenn r mattes president  ceo director    award at  per share   stefan proniuk chief development officer    award at  per share   commercial street capital llc    acquisition at  per share   arie s belldegrun director    acquisition at  per share   arie s belldegrun director    acquisition at  per share   arie s belldegrun director    acquisition at  per share   arie s belldegrun director    acquisition at  per share   alexander a zukiwski chief executive officer  cmo director    acquisition at  per share   glenn r mattes president  ceo director    acquisition at  per share   william f hamilton director    acquisition at  per share   commercial street capital llc    derivativenonderivative trans at  per share   arie s belldegrun director    derivativenonderivative trans at  per share   arie s belldegrun director    derivativenonderivative trans at  per share   arie s belldegrun director    derivativenonderivative trans at  per share   arie s belldegrun director    derivativenonderivative trans at  per share   alexander a zukiwski chief executive officer  cmo director    derivativenonderivative trans at  per share   glenn r mattes president  ceo director    derivativenonderivative trans at  per share   stefan proniuk chief development officer    derivativenonderivative trans at  per share   wexford capital lp    disposition at  per share   commercial street capital llc      arie s belldegrun director      arie s belldegrun director      arie s belldegrun director      arie s belldegrun director      alexander a zukiwski chief executive officer  cmo director      glenn r mattes president  ceo director      stefan proniuk chief development officer      ralph h thurman director    acquisition at  per share   ralph h thurman director    acquisition at  per share   commercial street capital llc      arie s belldegrun director      arie s belldegrun director      arie s belldegrun director      arie s belldegrun director      alexander a zukiwski chief executive officer  cmo director      glenn r mattes president  ceo director      stefan proniuk chief development officer      commercial street capital llc      arie s belldegrun director      arie s belldegrun director      arie s belldegrun director      arie s belldegrun director      alexander a zukiwski chief executive officer  cmo director      glenn r mattes president  ceo director      stefan proniuk chief development officer     newslatestcompanyusarni marketwatch news on arni no news currently available for arni newsnonmarketwatchcompanyusarni other news on arni tracking george soross portfolio  q  update  am feb    seeking alpha q arno therapeutics inc  pm nov    edgar online  edg  q k q arno therapeutics inc  pm aug    edgar online  edg  q k arno therapeutics to raise m via direct placement  am aug    seeking alpha past failures set arno therapeutics up for success  am jan    seeking alpha insiders roundup top buys sales of the week  pm jan    gurufocuscom opko health why recent weakness represents a golden buying opportunity  am july    seeking alpha small cap biotechs under  billion market cap to watch into asco   am may    seeking alpha biotech weekly small cap biotechs under  billion market cap to watch into asco   am may    seeking alpha arno therapeutics a likely acquisition for opko  pm dec    seeking alpha hedge funds raise largecap holdings  pm feb    the wall street journal interactive edition at a glance arno therapeutics inc  route  north suite  flemington new jersey  phone   industry biotechnology sector health carelife sciences fiscal yearend  view sec filings revenue na net income m employees  annual report for arni newspressreleasecompanyusarni press releases on arni no news currently available for arni trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest areckitt benckiser profit rises on reduced costs achinese regulator tells insurers to shape up arandgold looks to get more out of tongon mine aryanair profit soars  warns on overcapacity asiemens and bombardier in talks to form train jvs avw asks eu to scrutinize german car makers akkr close to announcing deal for webmd ajulius baer assets under management jump aroyal philips profit rises begins share buybacks aryanair profit rises  beating expectations ahow opec committee’s coming meeting could make or break oil prices aoil prices steady with all eyes on opec meeting ajapan aussie stocks knocked by weak dollar commodity prices aimf cuts us growth forecast for   p‘game of thrones’ the four biggest takeaways from stormborn’ pwhy you’re more likely to die in an accident during the summer months pthese wealthy parents spend  for summer camps so their kids can be ‘normal’ p totally avoidable reasons why millennials can’t have nice things or save any money phow elon musk and shorter commutes could transform people’s lives pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  arno therapeutics inc  product pipeline review    rnr market research advanced search     salesrnrmarketresearchcom search market research reports ﻿ market research assistance salesrnrmarketresearchcom on the web related markets biotechnologybiomaterialsbiomarkersstem celldrug discoveryindustrial biotechnologywound careenzymemicroarraybiopharmaceuticalcell culture related market reportsarno therapeutics inc  product pipeline review   home  life sciences  pharmaceuticals  report detail arno therapeutics inc  product pipeline review   publisher name  global markets direct date jul no of pages  price single user license us  corporate user license us  report descriptiontable of contentnews  blogother reportsour offerings global markets directs arno therapeutics inc product pipeline review  provides an overview of the arno therapeutics incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of arno therapeutics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope the report provides brief overview of arno therapeutics inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of arno therapeutics incs human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the arno therapeutics incs pipeline products reasons to buy evaluate arno therapeutics incs strategic position with total access to detailed information on its product pipeline assess the growth potential of arno therapeutics inc in its therapy areas of focus identify new drug targets and therapeutic classes in the arno therapeutics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of arno therapeutics inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of arno therapeutics inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of arno therapeutics inc and identify potential opportunities in those areas avoid intellectual property rights related issues arno therapeutics inc  product pipeline review   table of contents table of contents  list of tables  list of figures  arno therapeutics inc snapshot  arno therapeutics inc overview  key information  key facts  arno therapeutics inc  research and development overview  key therapeutic areas  arno therapeutics inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  arno therapeutics inc  pipeline products glance  arno therapeutics inc  clinical stage pipeline products  phase i productscombination treatment modalities  arno therapeutics inc  early stage pipeline products  preclinical productscombination treatment modalities  arno therapeutics inc  drug profiles  ar  product description  mechanism of action  rd progress  onapristone er  product description  mechanism of action  rd progress  ar  product description  mechanism of action  rd progress  arno therapeutics inc  pipeline analysis  arno therapeutics inc  pipeline products by target  arno therapeutics inc  pipeline products by route of administration  arno therapeutics inc  pipeline products by molecule type  arno therapeutics inc  pipeline products by mechanism of action  arno therapeutics inc  recent pipeline updates  arno therapeutics inc  dormant projects  arno therapeutics inc  discontinued pipeline products  discontinued pipeline product profiles  ar  arno therapeutics inc  company statement  arno therapeutics inc  locations and subsidiaries  head office  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables arno therapeutics inc key information  arno therapeutics inc key facts  arno therapeutics inc  pipeline by indication   arno therapeutics inc  pipeline by stage of development   arno therapeutics inc  monotherapy products in pipeline   arno therapeutics inc  phase i   arno therapeutics inc  preclinical   arno therapeutics inc  pipeline by target   arno therapeutics inc  pipeline by route of administration   arno therapeutics inc  pipeline by molecule type   arno therapeutics inc  pipeline products by mechanism of action   arno therapeutics inc  recent pipeline updates   arno therapeutics inc  dormant developmental projects  arno therapeutics inc  discontinued pipeline products   list of figures arno therapeutics inc  pipeline by top  indication   arno therapeutics inc  pipeline by stage of development   arno therapeutics inc  monotherapy products in pipeline   arno therapeutics inc  pipeline by top  target   arno therapeutics inc  pipeline by top  route of administration   arno therapeutics inc  pipeline by top  molecule type   arno therapeutics inc  pipeline products by top  mechanism of action   highspeed data transmission and high volume needs propel fiber optic connectors market fiber optic connectors are a substantial fragment of the global telecommunication industry optical fibers are joined using fiber optic connectors which allow the light conduction between two consecutive optical fibers an additional im…extensive use of digital technologies for diagnostic applications to boost global optical imaging market the global optical imaging system market is predicted to reach us  billion by  it is expected to grow at a stable rate and will post a cagr of more than  in the coming years the growing market infiltration of digital …foremost trends in global pet care market the global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments it is estimated that the global pet care market will grow at a cagr o…china to review its food security laws china has arisen as the globe’s firmest developing economy in addition china brags about the biggest population pool in the world in recent times the one child policy in the republic was terminated this is anticipated to upsur…improving standards of living to boost global consumer durables market consumer durables is a cataloguing of consumer goods that are not essential to be bought very often as they are fashioned in a way so as to last for an extended period of time profits in the consumer durables sector were most profoundly…  philippines vaginal pessary market report status and outlook published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in philippines from the xx million usd in  with a cagr compound annual growth rate xx from  to  in malaysia market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac   united states vaginal pessary market report status and outlook published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in united states from the xx million usd in  with a cagr compound annual growth rate xx from  to  in united states market the top players include coopersurgical medgyn personal medical corp integra lifesciences  north america physiological saline market by manufacturers countries type and application forecast to  published jul        price us  onwards        pages  physiological saline is a mixture of sodium chloride in water and has a number of uses in medicine applied to the affected area it is used to clean wounds help remove contact lenses and help with dry eyes by injection into a vein it is used to treat dehydration such as from gastroenteritis and diabetic ketoacidosis it is also used to dilute other medications to be given by injection scope of the report this report focuses on the physiological saline in north  europe dunaliella market by manufacturers countries type and application forecast to  published jul        price us  onwards        pages  dunaliella is a genus of the algae family dunaliellaceae it is widely distributed in natural habitat ranging from ocean and lakes of saturated brine dunaliella is unicellular biflagellate naked greenalga with ovoid in shape without cell wall  µm wide and  µm long it is the plant containing the highest amount of carotenoids including alphacarotene betacarotene zeaxanthin lutein cryptoxanthin and lycopene and abundant unsaturated fatty acid especially linolenic acid henc  top  vaginal pessary manufacturers in north america europe asiapacific south america middle east and africa published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the global vaginal pessary market size will be xx million usd in  from the xx million usd in  with a cagr compound annual growth rate xx from  to  this report studies vaginal pessary in global market especially in north america europe asiapacific south america middle east and africa focuses on the top  vaginal pessary players in each reg  china vaginal pessary market report status and outlook published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in china from the xx million usd in  with a cagr compound annual growth rate xx from  to  in china market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical  global top countries vaginal pessary market report published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the global vaginal pessary market size will be xx million usd in  from the xx million usd in  with a cagr compound annual growth rate xx from  to  this report studies vaginal pessary in global market especially in united states canada mexico germany france uk italy russia china japan india korea southeast asia australia brazil mi  india vaginal pessary market report status and outlook published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in india from the xx million usd in  with a cagr compound annual growth rate xx from  to  in india market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical  japan vaginal pessary market report status and outlook published jul        price us  onwards        pages  this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in japan from the xx million usd in  with a cagr compound annual growth rate xx from  to  in japan market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical services value for money we believe in optimum utilization of available budget and resources while servicing our clients your market research requirements we keep the same approach in focus to help you get the best value for your s ever growing inventory ranging from the smallest feasible  required data datasheets data facts swot analysis company profiles etc to full research reports that help you make decisions our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than  niche sectors one stop solution need a custom research report on medical devices market require all available business intelligence on d printing industry exploring fb sector of a particular countryregion rnrmarketresearchcom is your onestopsolution to all market intelligence needs we not only offer custom research and consulting services we also bundle reports to meet your needs and help you fetch the data analysis you require for your business dedicated client engagement not limited to only finding relevant reports for you our client engagement team dedicates its efforts to understand your business need and accordingly maps available research data to help you move forward call your client engagement executive any time of your day and get your questions answered in order to make the correct business decision saving time and efforts simply share your research requirement details with us and let us do all the hard work to find required intelligence for you when you add up our one stop solution and dedicated client engagement services mentioned above you obviously know the time and effort saving you do by working with us payment flexibility working with fortune  organizations we understand the importance of being flexible for payments share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done postpurchase research support have questions after reading a report  datasheet bought through us not sure about the methodology used for data available in the research talk to us  share your questions with us and if required we will connect you with the analystsauthors of the reports and ensure you get satisfactory answers for the same need more data  analysis  reports on the topic of your researchproject the rnrmarketresearchcom team is here for you x to support you with your postpurchase requirements subscription offers  packages get in touch with us for more details  salesrnrmarketresearchcom       ad hoc pay  as  you  go  bucket subscriptions fixed cost for of reports customize  personalize as per your needs avail upto  discount on below publisher reports azoth analytics technavio pharmaceuticals market research reports on market size and competitive analysis advanced search     salesrnrmarketresearchcom search market research reports market research assistance salesrnrmarketresearchcomon the web refine resultby datelast monthlast  monthslast  monthslast yearlast  years by price  home     life sciences    pharmaceuticals pharmaceuticals market research reports the global pharmaceutical market has persistently experienced significant growth due to the everincreasing demand for novel and more effective drugs the reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth newer and more complex disease conditions ageing population and the increased prevalence of chronic and infectious diseases some of which still remain incurable and fatal such numerous unmet needs and high demand rates have triggered the boost in rd investments by key industry sectors greatly driving the growth of this industry the pharmaceutical market valued as a multibillion dollar market is undoubtedly the largest revenue generator for the life sciences industry the pharmaceutical industry can be divided into numerous market segments based on the different therapeutic areas and applications the largest segment the market for cardiovascular drugs records huge sales every year the rising world population rapview more the global pharmaceutical market has persistently experienced significant growth due to the everincreasing demand for novel and more effective drugs the reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth newer and more complex disease conditions ageing population and the increased prevalence of chronic and infectious diseases some of which still remain incurable and fatal such numerous unmet needs and high demand rates have triggered the boost in rd investments by key industry sectors greatly driving the growth of this industry the pharmaceutical market valued as a multibillion dollar market is undoubtedly the largest revenue generator for the life sciences industry the pharmaceutical industry can be divided into numerous market segments based on the different therapeutic areas and applications the largest segment the market for cardiovascular drugs records huge sales every year the rising world population rapid ageing of the same and an increased prevalence of diseases are the major factors driving growth of this industry the recent breakthroughs in proteomics and genomics have led to the development of modernized approaches to drug discovery and development in the industry for the possibility of newer advanced and more sophisticated therapies and drugs developments in biotechnology research have led to introduction of advanced therapies involving biopharmaceuticals regenerative medicine stem cells etc these new age therapies and products have caused ease of treatment procedures and enabled speedy recovery from various disorders technological growth in such interdisciplinary fields has opened up new arenas in drug discovery drug delivery and life sciences researchview less therapeuticsdiseases  treatmentclinical trialdietary supplementsbiopharmaceuticalspharmaceutical packagingpain managementpandemic vaccinebiosimilarpharmaceutical distributionover the counter otc druganesthesia drugscancer vaccinepharmaceutical technologyradiopharmaceuticalprescription drugspharmaceutical detailingclinical nutrition pharmaceuticals market research reports titlepublishedprice europe injectable anticoagulants market by manufacturers countries type and application forecast to by global info research is andor treatment of venous thromboembolism scope of the report this report focuses on the injectable anticoagulants in europe market especially in germany uk france russia and italy this report categorizes thjul europe ginseng extract market by manufacturers countries type and application forecast to by global info research ving antiinflammatory anticancer and antioxidant properties it is also used in the homeopathic treatment of conditions including depression stress low libido and attention deficit hyperactivity disorder adhd scope of the rejul europe dunaliella market by manufacturers countries type and application forecast to by global info research ntaining the highest amount of carotenoids including alphacarotene betacarotene zeaxanthin lutein cryptoxanthin and lycopene and abundant unsaturated fatty acid especially linolenic acid hence it is university acknowledged of the commerciajul europe anticoagulants market by manufacturers countries type and application forecast to by global info research mal to obtain some blood as a class of medications anticoagulants are used in therapy for thrombotic disorders oral anticoagulants oacs are taken by many people in pill or tablet form and various intravenous anticoagulant dosage forms are used jul north america physiological saline market by manufacturers countries type and application forecast to by global info research diabetic ketoacidosis it is also used to dilute other medications to be given by injection scope of the report this report focuses on the physiological saline in north america market especially in united states canajul global onychomycosis tinea unguium drug detailed analysis report by qyresearch group oduct type by consumers and also their price change details as a detailed analysis report it covers all details inside analysis and opinion in onychomycosis tinea unguium drug industry this report focus global market it covers djul  united states vaginal pessary market report status and outlookby lp information inc  in united states market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical medesign smijul  united states tuberculin market report status and outlookby lp information inc r  in united states market the top players include sanofi pasteur zoetis par sterile ssi japan bcg thermo fisher sanroad biological cnbgjul  philippines vaginal pessary market report status and outlookby lp information inc in malaysia market the top players include coopersurgical medgyn personal medical corp integra lifesciences panpac medical medesign smiths medjul  philippines tuberculin market report status and outlookby lp information inc  in malaysia market the top players include sanofi pasteur zoetis par sterile ssi japan bcg thermo fisher sanroad biological cnbgjul                 next » avail upto  discount on below publisher reports azoth analytics technavio arni stock price  arno therapeutics inc stock quote us otc  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers ctas  cof  etfc  syf  hp  isrg  hban  chk  latest newsall times eastern a reckitt benckiser profit rises on reduced costs a chinese regulator tells insurers to shape up a randgold looks to get more out of tongon mine a ryanair profit soars  warns on overcapacity a siemens and bombardier in talks to form train jvs a vw asks eu to scrutinize german car makers a kkr close to announcing deal for webmd a julius baer assets under management jump a royal philips profit rises begins share buybacks a ryanair profit rises  beating expectations to be replaced home investing quotes stocks united states arni overview compare quotes stock screener earnings calendar sectors arni us otc join td ameritrade find a broker arno therapeutics inc watchlist createarnialert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta na rev per employee na pe ratio na eps  yield na dividend na exdividend date na short interest na na  of float shorted na average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones no headlines available up and down the ladder the latest comings and goings at covance bristol and… jul   at  am et on the wall street journal hedge funds raise largecap holdings feb   at  pm et on the wall street journal recent news other news press releases tracking george soross portfolio  q  update feb   at  am et on seeking alpha q arno therapeutics inc nov   at  pm et on edgar online  edg  q k q arno therapeutics inc aug   at  pm et on edgar online  edg  q k arno therapeutics to raise m via direct placement aug   at  am et on seeking alpha past failures set arno therapeutics up for success jan   at  am et on seeking alpha insiders roundup top buys sales of the week jan   at  pm et on gurufocuscom opko health why recent weakness represents a golden buying opportunity jul   at  am et on seeking alpha small cap biotechs under  billion market cap to watch into asco  may   at  am et on seeking alpha biotech weekly small cap biotechs under  billion market cap to watch into asco  may   at  am et on seeking alpha arno therapeutics a likely acquisition for opko dec   at  pm et on seeking alpha hedge funds raise largecap holdings feb   at  pm et on the wall street journal no headlines available arno therapeutics inc arno therapeutics inc operates as a biopharmaceutical company which focuses on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs it develops preclinical and clinicalstage product under the following brands onapristone ar and ar the company was founded by peter morgan kash david m tanen and joshua a kazam in march  and is headquartered in flemington nj see full profile competitors name chg  market cap nektar therapeutics  b sucampo pharmaceuticals inc cl a  m medicinova inc  m chimerix inc  m catalyst biosciences inc  m competitor data provided by partner content trending tickers powered by googl  crbp  bzun  itw  nyt  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience stocks index  markets index bulletin investor alert london markets open in asia markets currencies us market snapshot stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest areckitt benckiser profit rises on reduced costs achinese regulator tells insurers to shape up arandgold looks to get more out of tongon mine aryanair profit soars  warns on overcapacity asiemens and bombardier in talks to form train jvs avw asks eu to scrutinize german car makers akkr close to announcing deal for webmd ajulius baer assets under management jump aroyal philips profit rises begins share buybacks aryanair profit rises  beating expectations ahow opec committee’s coming meeting could make or break oil prices aoil prices steady with all eyes on opec meeting ajapan aussie stocks knocked by weak dollar commodity prices aimf cuts us growth forecast for   p‘game of thrones’ the four biggest takeaways from stormborn’ pwhy you’re more likely to die in an accident during the summer months pthese wealthy parents spend  for summer camps so their kids can be ‘normal’ p totally avoidable reasons why millennials can’t have nice things or save any money phow elon musk and shorter commutes could transform people’s lives pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert london markets open in asia markets currencies us market snapshot stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest areckitt benckiser profit rises on reduced costs achinese regulator tells insurers to shape up arandgold looks to get more out of tongon mine aryanair profit soars  warns on overcapacity asiemens and bombardier in talks to form train jvs avw asks eu to scrutinize german car makers akkr close to announcing deal for webmd ajulius baer assets under management jump aroyal philips profit rises begins share buybacks aryanair profit rises  beating expectations ahow opec committee’s coming meeting could make or break oil prices aoil prices steady with all eyes on opec meeting ajapan aussie stocks knocked by weak dollar commodity prices aimf cuts us growth forecast for   p‘game of thrones’ the four biggest takeaways from stormborn’ pwhy you’re more likely to die in an accident during the summer months pthese wealthy parents spend  for summer camps so their kids can be ‘normal’ p totally avoidable reasons why millennials can’t have nice things or save any money phow elon musk and shorter commutes could transform people’s lives pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin investor alert london markets open in asia markets currencies us market snapshot stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest areckitt benckiser profit rises on reduced costs achinese regulator tells insurers to shape up arandgold looks to get more out of tongon mine aryanair profit soars  warns on overcapacity asiemens and bombardier in talks to form train jvs avw asks eu to scrutinize german car makers akkr close to announcing deal for webmd ajulius baer assets under management jump aroyal philips profit rises begins share buybacks aryanair profit rises  beating expectations ahow opec committee’s coming meeting could make or break oil prices aoil prices steady with all eyes on opec meeting ajapan aussie stocks knocked by weak dollar commodity prices aimf cuts us growth forecast for   p‘game of thrones’ the four biggest takeaways from stormborn’ pwhy you’re more likely to die in an accident during the summer months pthese wealthy parents spend  for summer camps so their kids can be ‘normal’ p totally avoidable reasons why millennials can’t have nice things or save any money phow elon musk and shorter commutes could transform people’s lives pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  arni stock price  arno therapeutics inc stock quote us otc  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers ctas  cof  etfc  syf  hp  isrg  hban  chk  latest newsall times eastern a reckitt benckiser profit rises on reduced costs a chinese regulator tells insurers to shape up a randgold looks to get more out of tongon mine a ryanair profit soars  warns on overcapacity a siemens and bombardier in talks to form train jvs a vw asks eu to scrutinize german car makers a kkr close to announcing deal for webmd a julius baer assets under management jump a royal philips profit rises begins share buybacks a ryanair profit rises  beating expectations to be replaced home investing quotes stocks united states arni overview compare quotes stock screener earnings calendar sectors arni us otc join td ameritrade find a broker arno therapeutics inc watchlist createarnialert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta na rev per employee na pe ratio na eps  yield na dividend na exdividend date na short interest na na  of float shorted na average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones no headlines available up and down the ladder the latest comings and goings at covance bristol and… jul   at  am et on the wall street journal hedge funds raise largecap holdings feb   at  pm et on the wall street journal recent news other news press releases tracking george soross portfolio  q  update feb   at  am et on seeking alpha q arno therapeutics inc nov   at  pm et on edgar online  edg  q k q arno therapeutics inc aug   at  pm et on edgar online  edg  q k arno therapeutics to raise m via direct placement aug   at  am et on seeking alpha past failures set arno therapeutics up for success jan   at  am et on seeking alpha insiders roundup top buys sales of the week jan   at  pm et on gurufocuscom opko health why recent weakness represents a golden buying opportunity jul   at  am et on seeking alpha small cap biotechs under  billion market cap to watch into asco  may   at  am et on seeking alpha biotech weekly small cap biotechs under  billion market cap to watch into asco  may   at  am et on seeking alpha arno therapeutics a likely acquisition for opko dec   at  pm et on seeking alpha hedge funds raise largecap holdings feb   at  pm et on the wall street journal no headlines available arno therapeutics inc arno therapeutics inc operates as a biopharmaceutical company which focuses on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs it develops preclinical and clinicalstage product under the following brands onapristone ar and ar the company was founded by peter morgan kash david m tanen and joshua a kazam in march  and is headquartered in flemington nj see full profile competitors name chg  market cap nektar therapeutics  b sucampo pharmaceuticals inc cl a  m medicinova inc  m chimerix inc  m catalyst biosciences inc  m competitor data provided by partner content trending tickers powered by googl  crbp  bzun  itw  nyt  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience  not found not found the requested url prhtml was not found on this server additionally a  not found error was encountered while trying to use an errordocument to handle the request